AstraZeneca
AZN
#49
Rank
NZ$477.59 B
Marketcap
NZ$154.04
Share price
0.19%
Change (1 day)
24.47%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): NZ$5.23

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is NZ$5.04. In 2024 the company made an earnings per share (EPS) of NZ$3.77 an increase over its 2023 EPS that were of NZ$3.19.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$5.2338.74%
2024NZ$3.7718.23%
2023NZ$3.1981.13%
2022NZ$1.76631.03%
2021NZ$0.24-88.11%
2020NZ$2.03136.89%
2019NZ$0.86-39.41%
2018NZ$1.41-28.27%
2017NZ$1.97-14.37%
2016NZ$2.3024.11%
2015NZ$1.85127.55%
2014NZ$0.81-51.96%
2013NZ$1.69-58.95%
2012NZ$4.13-32.2%
2011NZ$6.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$17.33 243.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.22 142.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.86-43.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.38 165.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$34.07 576.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$6.15 22.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$18.25 262.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.61 150.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$4.93-2.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.97 18.48%๐Ÿ‡ฌ๐Ÿ‡ง UK